In a study of individuals with ( N = 36) or without ( N = 19) upper gastrointestinal disease (gastritis and/or gastroesophageal reflux disease), no significant difference in exposure to semaglutide was observed between individuals with or without gastrointestinal disease and the agent was well tolerated in these patients [35]
You deserve to feel strong, empowered, and confident in your body, no matter what stage youre at
When medication and lifestyle work together, patients often experience steady, sustainable progress
Gastrointestinal safety of semaglutide and tirzepatide vs placebo in obese individuals without diabetes: systematic review and meta-analysis
As of February 2024, 15 GLP-1 medications had received FDA approval for blood sugar and weight control, with more in development
Whereas plain glutathione must be broken down by enzymes to the basic amino acid components for absorption into the cell requiring more energy expenditure to be re-constructed back to reduced glutathione (rGSH)